| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chairman Of Oncology
2 companies
McCormick Frank is a Director at BridgeBio Pharma, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 22 sells.
Estimated insider holdings value: $52.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 198,359 | $66.58 | $13,206,527.70 | -5.2% | +16.9% | - | |
| Oct 27, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 1,641 | $65.00 | $106,665.00 | -0.2% | +22.4% | - | |
| Sep 5, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 74,000 | $53.16 | $3,933,544.00 | -47.1% | +40.1% | - | |
| Jun 24, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 100,000 | $44.23 | $4,422,800.00 | -10.2% | +16.0% | - | |
| Dec 26, 2023 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 100,000 | $42.06 | $4,206,000.00 | -13.7% | -30.0% | -32.4% | |
| Nov 13, 2020 | BBIO Bridgebio Pharma, Inc. | Chairman Of Oncology | Sell | 100,000 | $42.76 | $4,275,768.84 | -2.6% | - | - | |
| Dec 30, 2019 | BBIO Bridgebio Pharma, Inc. | Chairman Of Oncology | Sell | 100,000 | $37.55 | $3,755,379.27 | -0.8% | - | - |